Clindamycin is a lincosamide antibiotic with activity against gram-positive cocci and many anaerobes.
EML status history
Therapeutic equivalent for
Access group antibiotics
- Oral > Liquid: 75 mg per 5 mL (as palmitate hydrochloride)
- Oral > Solid: 150 mg (as hydrochloride) capsule
- Parenteral > General injections > unspecified: 150 mg per mL (as phosphate) injection